Resultados de la búsqueda

Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov (2011) 10:835-52
Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview. Circulation (2011) 123:768-78
Fuster V, Kelly BB, Vedanthan R. Promoting global cardiovascular health: moving forward Circulation (2011) 123:1671-8
Kovacic JC, Moreno P, Hachinski V, Nabel EG, Fuster V Cellular senescence, vascular disease, and aging: part 1 of a 2-part review Circulation (2011) 123:1650-60
Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V. Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation (2011) 123:1900-10
Fuster V, Kelly BB, Vedanthan R. Global cardiovascular health urgent need for an intersectoral approach. J Am Coll Cardiol (2011) 58:1208-10
Klink A, Heynens J, Herranz B, Lobatto ME, Arias T, Sanders HM, Strijkers GJ, Merkx M, Nicolay K, Fuster V, Tedgui A, Mallat Z, Mulder WJ, Fayad ZA. In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J Am Coll Cardiol (2011) 58:2522-30
Hyafil F, Vucic E, Cornily JC, Sharma R, Amirbekian V, Blackwell F, Lancelot E, Corot C, Fuster V, Galis ZS, Feldman LJ, Fayad ZA. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. Eur Heart J (2011) 32:1561-71
García-Alvarez A, Fernández-Friera L, Mirelis JG, Sawit S, Nair A, Kallman J, Fuster V, Sanz J. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. Eur Heart J (2011) 32:1438-45

Pages